UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Validation of multisource electronic health record data: an application to blood transfusion data

BMC medical informatics and decision making, 2017-07, Vol.17 (1), p.107-107, Article 107

2017

Volltextzugriff (PDF)

Travel and the risk of symptomatic venous thromboembolism

Thrombosis and haemostasis, 2003-03, Vol.89 (3), p.499-505

2003

Volltextzugriff (PDF)

Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home

The New England journal of medicine, 1996-03, Vol.334 (11), p.682-687

1996

Volltextzugriff (PDF)

Monitoring health related quality of life in survivorship care of young adult survivors of childhood cancer using web-based patient-reported outcome measures: survivors’ and health care practitioners’ perspectives on the KLIK method

Quality of life research, 2024, Vol.33 (1), p.145-156

2024

Volltextzugriff (PDF)

Long-Term Risk of Subsequent Neoplasms in 5-Year Survivors of Childhood Neuroblastoma: A Dutch Childhood Cancer Survivor Study-LATER 3 Study

Journal of clinical oncology, 2024-10

2024

Volltextzugriff (PDF)

Neuroblastoma survivors at risk for developing subsequent neoplasms: A systematic review

Cancer treatment reviews, 2022-03, Vol.104, p.102355-102355, Article 102355

2022

Volltextzugriff (PDF)

Long-term treatment of venous thromboembolic disease

Thrombosis and haemostasis, 1999-08, Vol.82 (2), p.892-898

1999

Volltextzugriff (PDF)

Unselected women with elevated levels of factor VIII:C or homocysteine are not at increased risk for obstetric complications

Thrombosis and haemostasis, 2004-10, Vol.92 (4), p.787-790

2004

Volltextzugriff (PDF)

Guidance regarding COVID‐19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group

Pediatric blood & cancer, 2020-12, Vol.67 (12), p.e28702-n/a

2020

Volltextzugriff (PDF)

Travel and risk of venous thrombosis

The Lancet (British edition), 2000-10, Vol.356 (9240), p.1492-1493

2000

Volltextzugriff (PDF)

Protocol for a national blood transfusion data warehouse from donor to recipient

BMJ open, 2016-08, Vol.6 (8), p.e010962-e010962

2016

Volltextzugriff (PDF)

Prospective study of color duplex ultrasonography compared with contrast venography in patients suspected of having deep venous thrombosis of the upper extremities

Annals of internal medicine, 2002-06, Vol.136 (12), p.865

2002

Volltextzugriff (PDF)

A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism

Annals of internal medicine, 2001-09, Vol.135 (5), p.322

2001

Volltextzugriff (PDF)

Effect on the quality of blood components after simulated blood transfusions using volumetric infusion pumps

Transfusion (Philadelphia, Pa.), 2011-08, Vol.51 (8), p.1835-1839

2011

Volltextzugriff (PDF)

Preventing TRALI: Ladies first, what follows?

Critical care medicine, 2008-12, Vol.36 (12), p.3283-3284

2008

Volltextzugriff (PDF)

High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia

American journal of obstetrics and gynecology, 1999-05, Vol.180 (5), p.1146-1150

1999

Volltextzugriff (PDF)

Short‐ and long‐acting synthetic pentasaccharides

Journal of internal medicine, 2003-10, Vol.254 (4), p.335-342

2003

Volltextzugriff (PDF)

The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis

Annals of internal medicine, 1998-01, Vol.128 (1), p.15

1998

Volltextzugriff (PDF)

Diagnosis and management of deep vein thrombosis of the upper extremity: a review

European radiology, 2004-07, Vol.14 (7), p.1263-1274

2004

Volltextzugriff (PDF)

Increased risk for fetal loss in carriers of the factor V Leiden mutation

Annals of internal medicine, 1999-05, Vol.130 (9), p.736

1999

Volltextzugriff (PDF)

Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism

Haematologica (Roma), 2002-10, Vol.87 (10), p.1068

2002

Volltextzugriff (PDF)

Low molecular weight heparin for outpatient treatment of venous thromboembolism

The American journal of medicine, 2003-09, Vol.115 (4), p.324-325

2003

Volltextzugriff (PDF)

The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disorders

British journal of haematology, 2002-03, Vol.116 (3), p.625-631

2002

Volltextzugriff (PDF)

Low molecular weight heparin for outpatient treatment of venous thromboembolism: safe, effective, and cost reducing?

The American journal of medicine, 2003-09, Vol.115 (4), p.324-325

2003

Volltextzugriff (PDF)

Long-term follow-up of patients with suspected deep vein thrombosis of the upper extremity: survival, risk factors and post-thrombotic syndrome

European journal of internal medicine, 2004-12, Vol.15 (8), p.503-507

2004

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Validation of multisource electronic health record data: an application to blood transfusion data

Travel and the risk of symptomatic venous thromboembolism

Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home

Monitoring health related quality of life in survivorship care of young adult survivors of childhood cancer using web-based patient-reported outcome measures: survivors’ and health care practitioners’ perspectives on the KLIK method

Long-Term Risk of Subsequent Neoplasms in 5-Year Survivors of Childhood Neuroblastoma: A Dutch Childhood Cancer Survivor Study-LATER 3 Study

Neuroblastoma survivors at risk for developing subsequent neoplasms: A systematic review

Long-term treatment of venous thromboembolic disease

Unselected women with elevated levels of factor VIII:C or homocysteine are not at increased risk for obstetric complications

Guidance regarding COVID‐19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group

Travel and risk of venous thrombosis

Protocol for a national blood transfusion data warehouse from donor to recipient

Prospective study of color duplex ultrasonography compared with contrast venography in patients suspected of having deep venous thrombosis of the upper extremities

A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism

Effect on the quality of blood components after simulated blood transfusions using volumetric infusion pumps

Preventing TRALI: Ladies first, what follows?

High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia

Short‐ and long‐acting synthetic pentasaccharides

The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis

Diagnosis and management of deep vein thrombosis of the upper extremity: a review

Increased risk for fetal loss in carriers of the factor V Leiden mutation

Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism

Low molecular weight heparin for outpatient treatment of venous thromboembolism

The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disorders

Low molecular weight heparin for outpatient treatment of venous thromboembolism: safe, effective, and cost reducing?

Long-term follow-up of patients with suspected deep vein thrombosis of the upper extremity: survival, risk factors and post-thrombotic syndrome

Suchergebnisse filtern